ArticleNeurosciences (Riyadh, Saudi Arabia)2026
Antiseizure Drug Adherence in Pediatric Patients With Epilepsy and the Associated Factors in Saudi Arabia.
Article in Neurosciences (Riyadh, Saudi Arabia), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To assess the prevalence of adherence to antiseizure medications and related factors in Saudi Arabia. Pediatric epilepsy presents significant challenges to the well-being and quality of life of children. Adherence to antiseizure medication is associated with better outcomes. Methods: This study was carried out using a cross-sectional methodology to determine the prevalence of antiseizure medication adherence among children with epilepsy aged ≤17 years in Saudi Arabia. Data were collected between July and September 2024 via an online self-administered questionnaire, using convenience sampling through social platforms (Telegram and WhatsApp). Medication adherence was assessed using the MMAS-8 and categorized as high (score = 8), medium (6-7), or low (<6); for analysis, scores ≥6 were considered adherent. Results: A total of 231 responses were analyzed. In terms of medication adherence, 42.0% of the participants were adherent (35.9% medium adherence and 6.1% high adherence), and 58% were non-adherent. Parents' and caregivers' knowledge was classified as good in 63.6% and poor in 36.4% of the participants, respectively. The result showed a statistically significant association between knowledge levels and adherence to antiseizure medication. Factors significantly associated with medication adherence included mothers as caregivers, taking medication once daily, no emergency room visits, and the use of other medications. Conclusion: Adherence to medications among pediatric patients with epilepsy remains suboptimal. The key factors associated with better adherence included mothers as primary caregivers, good caregiver knowledge, taking medication once daily, and less frequent emergency room visits. This study highlights the importance of increased awareness and education to improve healthcare delivery and enhance knowledge and attitudes toward epilepsy management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.